OTC Medicines Corner

SORT BY:     Most Recent      Most Viewed
  • April 1, 2007
    PREVIEW

    For cardioprotection, doses of aspirin higher than 75 to 81 mg daily are not supported by available evidence, based on findings of a trial reported recently in JAMA. Higher doses are...

  • February 1, 2007
    PREVIEW

    The abuse of the OTC ingredient dextromethorphan has been growing steadily for several years, particularly in the adolescent age group. Perceived safety, ease of availability, and desired...

  • December 1, 2006
    PREVIEW

    FDA has proposed amending the labeling regulations for nonprescription Internal Analgesic, Antipyretic, and Antirheumatic (IAAA) drug products to emphasize more strongly the potential for...

  • October 1, 2006
    PREVIEW

    The need for a law creating a behind-the-counter category of products in U.S. pharmacies is a central discussion point in the ongoing debate over the wisdom of making low-dose statins available...

  • August 1, 2006
    PREVIEW

    FDA has approved Plan B, the levonorgestrel emergency contraceptive marketed in the United States by Barr Laboratories’ subsidiary Duramed, for over-thecounter sales to women aged 18 years and...

Pages